1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.
    Healthcare Shares

    ASX 200 better buy: Cochlear or CSL shares?

    | Cathryn Goh

    Here's a bull case for each of these healthcare juggernauts.

    Read more »

    Two young men jump off a cliff into the water.
    Healthcare Shares

    The CSL share price dips as the ASX 200 dives on Wednesday

    | Aaron Teboneras

    CSL shares are falling wayside on Wednesday.

    Read more »

    Two happy scientists analysing test results in a lab
    Healthcare Shares

    Can the CSL share price regain its 52-week high in 2022?

    | Sebastian Bowen

    One broker is optimistic on the outlook for CSL shares.

    Read more »

    Blue Chip Shares

    Experts name 2 blue chip ASX shares to buy that Warren Buffett would love

    | James Mickleboro

    Are these blue chips that Warren Buffett would buy?

    Read more »

    A couple sits in their lounge room with a large piggy bank on the coffee table. They smile while the male partner feeds some money into the slot while the female partner looks on with an iPad style device in her hands as though they are budgeting.
    Dividend Investing

    The CSL dividend just got updated. How much will you be getting?

    | Aaron Teboneras

    There's some good news for CSL shareholders today...

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    The CSL share price is still trading just 10% above its COVID-crash low. Is it a buy?

    | Sebastian Bowen

    Are CSL shares finally about to give investors some gains?

    Read more »

    A businessman in soft-focus holds two fingers in the air in the foreground of the shot as he stands smiling in the background against a clear sky.
    Ask a Fund Manager

    Fundie reveals the 2 ASX shares he'd buy and hold for 4 years

    | Tony Yoo

    Ask A Fund Manager: SG Hiscock's Hamish Tadgell reveals the stocks he'd tuck away in the bottom drawer for long-term…

    Read more »

    Three boys dressed as knights wield swords as they defend their castle wall.
    Opinions

    Should all ASX investors be buying defensive shares right now?

    | Tristan Harrison

    Emma Fisher of Airlie Funds Management gives her views on defensive ASX shares.

    Read more »

    A scientist examining test results.
    Healthcare Shares

    Why is the CSL share price on the slide today?

    | Sebastian Bowen

    Shares in the ASX healthcare giant are holding their own on Tuesday.

    Read more »

    A medical researcher in a white coat holds laboratory equipment and smiles.
    Dividend Investing

    Want to snare the next CSL dividend? Read this

    | Aaron Teboneras

    It's going to be a big day for CSL shares tomorrow...

    Read more »

    High Five, happy, business
    Dividend Investing

    5 ASX 200 shares turning ex-dividend tomorrow

    | Cathryn Goh

    These dividends won't be around for much longer...

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Why is the CSL share price outperforming the ASX 200 on Friday?

    | Mitchell Lawler

    Investors might be happy about the CEO getting paid more... here's why.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note